Viral Vector Production

Viral Vector Production is a methodological framework in gene therapy manufacturing that entails the systematic generation of viral vectors through the controlled cultivation of genetically engineered host cells in bioreactor systems, distinguished by its reliance on optimized perfusion and single-use bioreactor technologies to ensure scalable, sterile, and high-titer vector output.

436

Publications

27.2K

Citations

2.1K

Authors

544

Institutions

Publications per year

2017–2026

127

Authors

2.1K

  1. AK
    Amine Kamen

    Biotechnology Research Institute, Canada

    27 publications · 1.6K citations

    24

    h-index

  2. PM
    Paula M. Alves

    Instituto de Biologia Experimental e Tecnológica, Portugal

    16 publications · 565 citations

    13

    h-index

  3. MJ
    Manuel J.T. Carrondo

    Instituto de Biologia Experimental e Tecnológica, Portugal

    14 publications · 618 citations

    12

    h-index

  4. SY
    Seppo Ylä‐Herttuala

    University of Eastern Finland, Finland

    9 publications · 550 citations

    9

    h-index

  5. SZ
    Sergei Zolotukhin

    University of Florida, United States

    8 publications · 627 citations

    8

    h-index

1–5 of 2.1K

Venues

  1. Human Gene Therapy

    45 publications · 5K citations

    33

    h-index

  2. 25

    h-index

  3. Gene Therapy

    30 publications · 1.8K citations

    23

    h-index

  4. Journal of Virology

    JVI · 22 publications · 2.9K citations

    20

    h-index

  5. Molecular Therapy

    22 publications · 2.2K citations

    19

    h-index

1–5